Cardiac-specific overexpreßion of human stem cell factor promotes epicardial activation and arteriogenesis after myocardial infarction

Circulation: Heart Failure

Volumn 7, Issue 5, 2014, Pages 831-842

  Xiang, Fu Li ^a   Liu, Yin ^a   Lu, Xiangru ^a   Jones, Douglas L ^a   Feng, Qingping ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Heart failureMyocardial infarction; Regeneration; Stem cell factor; Stem cells

Indexed keywords

STEM CELL FACTOR; TETRACYCLINE; MESSENGER RNA;

ADENOVIRIDAE; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIOLE; ARTICLE; CELL DENSITY; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; CELL REGENERATION; CONTROLLED STUDY; EPICARDIUM; GENE OVEREXPRESSION; HEART INFARCTION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSGENIC MOUSE; ANIMAL; BIOSYNTHESIS; CELL CULTURE; CORONARY BLOOD VESSEL; DISEASE MODEL; GENE EXPRESSION REGULATION; GENETICS; HEART MUSCLE CELL; IMMUNOHISTOCHEMISTRY; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); NEWBORN; PATHOLOGY; PERICARDIUM; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; ANIMALS, NEWBORN; BLOTTING, WESTERN; CELL PROLIFERATION; CELLS, CULTURED; CORONARY VESSELS; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; MICE, TRANSGENIC; MYOCARDIAL INFARCTION; MYOCYTES, CARDIAC; NEOVASCULARIZATION, PATHOLOGIC; PERICARDIUM; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; STEM CELL FACTOR;

EID: 84922153362     PISSN: 19413289     EISSN: 19413297     Source Type: Journal    
DOI: 10.1161/CIRCHEARTFAILURE.114.001423     Document Type: Article

References (45)

1. Mensah GA, Brown DW. An overview of cardiovascular disease burden in the United States. Health Affairs. 2007;26:38-48.
2. Ptaszek LM, Mansour M, Ruskin JN, Chien KR. Towards regenerative therapy for cardiac disease. Lancet. 2012;379:933-942.
3. Cai CL, Martin JC, Sun Y, Cui L, Wang L, Ouyang K, Yang L, Bu L, Liang X, Zhang X, Stallcup WB, Denton CP, McCulloch A, Chen J, Evans SM. A myocardial lineage derives from Tbx18 epicardial cells. Nature. 2008;454:104-108.
4. Zhou B, Ma Q, Rajagopal S, Wu SM, Domian I, Rivera-Feliciano J, Jiang D, von Gise A, Ikeda S, Chien KR, Pu WT. Epicardial progenitors contribute to the cardiomyocyte lineage in the developing heart. Nature. 2008;454:109-113.
5. Smart N, Dubé KN, Riley PR. Coronary veßel development and insight towards neovascular therapy. Int J Exp Pathol. 2009;90:262-283.
6. Winter EM, Grauß RW, Hogers B, van Tuyn J, van der Geest R, Lie-Venema H, Steijn RV, Maas S, DeRuiter MC, deVries AA, Steendijk P, Doevendans PA, van der Laarse A, Poelmann RE, Schalij MJ, Atsma DE, Gittenberger-de Groot AC. Preservation of left ventricular function and attenuation of remodeling after transplantation of human epicardium-derived cells into the infarcted mouse heart. Circulation. 2007;116:917-927.
7. Männer J, Pérez-Pomares JM, Macías D, Muñoz-Chápuli R. The origin, formation and developmental significance of the epicardium: a review. Cells Tißues Organs. 2001;169:89-103.
8. del Monte G, Casanova JC, Guadix JA, MacGrogan D, Burch JB, Pérez-Pomares JM, de la Pompa JL. Differential Notch signaling in the epicardium is required for cardiac inflow development and coronary veßel morphogenesis. Circ Res. 2011;108:824-836.
9. Gittenberger-de Groot AC, Winter EM, Bartelings MM, Goumans MJ, DeRuiter MC, Poelmann RE. The arterial and cardiac epicardium in development, disease and repair. Differentiation. 2012;84:41-53.
10. Wu B, Zhang Z, Lui W, Chen X, Wang Y, Chamberlain AA, Moreno-Rodriguez RA, Markwald RR, O'Rourke BP, Sharp DJ, Zheng D, Lenz J, Baldwin HS, Chang CP, Zhou B. Endocardial cells form the coronary arteries by angiogenesis through myocardial-endocardial VEGF signaling. Cell. 2012;151:1083-1096.
11. Red-Horse K, Ueno H, Weißman IL, Krasnow MA. Coronary arteries form by developmental reprogramming of venous cells. Nature. 2010;464:549-553.
12. von Gise A, Zhou B, Honor LB, Ma Q, Petryk A, Pu WT. WT1 regulates epicardial epithelial to mesenchymal transition through ß-catenin and retinoic acid signaling pathways. Dev Biol. 2011;356:421-431.
13. Pérez-Pomares JM, Phelps A, Sedmerova M, Carmona R, González-Iriarte M, Muñoz-Chápuli R, Weßels A. Experimental studies on the spatiotemporal expreßion of WT1 and RALDH2 in the embryonic avian heart: a model for the regulation of myocardial and valvuloseptal development by epicardially derived cells (EPDCs). Dev Biol. 2002;247:307-326.
14. Moore AW, McInnes L, Kreidberg J, Hastie ND, Schedl A. YAC complementation shows a requirement for Wt1 in the development of epicardium, adrenal gland and throughout nephrogenesis. Development. 1999;126:1845-1857.
15. Carmona R, González-Iriarte M, Pérez-Pomares JM, Muñoz-Chápuli R. Localization of the Wilm's tumour protein WT1 in avian embryos. Cell Tißue Res. 2001;303:173-186.
16. Limana F, Zacheo A, Mocini D, Mangoni A, Borsellino G, Diamantini A, De Mori R, Battistini L, Vigna E, Santini M, Loiaconi V, Pompilio G, Germani A, Capogroßi MC. Identification of myocardial and vascular precursor cells in human and mouse epicardium. Circ Res. 2007;101:1255-1265.
17. Limana F, Capogroßi MC, Germani A. The epicardium in cardiac repair: from the stem cell view. Pharmacol Ther. 2011;129:82-96.
18. Smith MA, Court EL, Smith JG. Stem cell factor: laboratory and clinical aspects. Blood Rev. 2001;15:191-197.
19. Friel J, Heberlein C, Itoh K, Ostertag W. Role of the stem cell factor (SCF) receptor and the alternative forms of its ligand (SCF) in the induction of long-term growth by stroma cells. Leukemia. 1997;11(suppl 3): 493-495.
20. Xiang FL, Lu X, Hammoud L, Zhu P, Chidiac P, Robbins J, Feng Q. Cardiomyocyte-specific overexpreßion of human stem cell factor improves cardiac function and survival after myocardial infarction in mice. Circulation. 2009;120:1065-1074.
21. Nishikawa S, Kusakabe M, Yoshinaga K, Ogawa M, Hayashi S, Kunisada T, Era T, Sakakura T, Nishikawa S. In utero manipulation of coat color formation by a monoclonal anti-c-kit antibody: two distinct waves of c-kit-dependency during melanocyte development. EMBO J. 1991;10:2111-2118.
22. Xiang FL, Lu X, Liu Y, Feng Q. Cardiomyocyte-specific overexpreßion of human stem cell factor protects against myocardial ischemia and reperfusion injury. Int J Cardiol. 2013;168:3486-3494.
23. Liu Y, Lu X, Xiang FL, Poelmann RE, Gittenberger-de Groot AC, Robbins J, Feng Q. Nitric oxide synthase-3 deficiency results in hypoplastic coronary arteries and postnatal myocardial infarction. Eur Heart J. 2014;35:920-931.
24. Zhang T, Lu X, Beier F, Feng Q. Rac1 activation induces tumour necrosis factor-a expreßion and cardiac dysfunction in endotoxemia. J Cell Mol Med. 2011;15:1109-1121.
25. Zhang T, Lu X, Li J, Chidiac P, Sims SM, Feng Q. Inhibition of Na/K-ATPase promotes myocardial tumor necrosis factor-alpha protein expreßion and cardiac dysfunction via calcium/mTOR signaling in endotoxemia. Basic Res Cardiol. 2012;107:254.
26. Moazzen H, Lu X, Ma NL, Velenosi TJ, Urquhart BL, Wiße LJ, Gittenberger-de Groot AC, Feng Q. N-Acetylcysteine prevents congenital heart defects induced by pregestational diabetes. Cardiovasc Diabetol. 2014;13:46.
27. Li N, Lu X, Zhao X, Xiang FL, Xenocostas A, Karmazyn M, Feng Q. Endothelial nitric oxide synthase promotes bone marrow stromal cell migration to the ischemic myocardium via upregulation of stromal cellderived factor-1alpha. Stem Cells. 2009;27:961-970.
28. Dedkov EI, Christensen LP, Weiß RM, Tomanek RJ. Reduction of heart rate by chronic beta1-adrenoceptor blockade promotes growth of arterioles and preserves coronary perfusion reserve in postinfarcted heart. Am J Physiol Heart Circ Physiol. 2005;288:H2684-H2693.
29. Anversa P, Capaßo JM. Loß of intermediate-sized coronary arteries and capillary proliferation after left ventricular failure in rats. Am J Physiol. 1991;260(5 pt 2):H1552-H1560.
30. Zhang T, Lu X, Arnold P, Liu Y, Baliga R, Huang H, Bauer JA, Liu Y, Feng Q. Mitogen-activated protein kinase phosphatase-1 inhibits myocardial TNF-a expreßion and improves cardiac function during endotoxemia. Cardiovasc Res. 2012;93:471-479.
31. Lie-Venema H, van den Akker NM, Bax NA, Winter EM, Maas S, Kekarainen T, Hoeben RC, deRuiter MC, Poelmann RE, Gittenberger-de Groot AC. Origin, fate, and function of epicardium-derived cells (EPDCs) in normal and abnormal cardiac development. ScientificWorldJournal. 2007;7:1777-1798.
32. Deten A, Höllzl A, Leicht M, Barth W, Zimmer HG. Changes in extracellular matrix and in transforming growth factor beta isoforms after coronary artery ligation in rats. J Mol Cell Cardiol. 2001;33:1191-1207.
33. Wünsch M, Sharma HS, Markert T, Bernotat-Danielowski S, Schott RJ, Kremer P, Bleese N, Schaper W. In situ localization of transforming growth factor beta 1 in porcine heart: enhanced expreßion after chronic coronary artery constriction. J Mol Cell Cardiol. 1991;23:1051-1062.
34. Zaruba MM, Soonpaa M, Reuter S, Field LJ. Cardiomyogenic potential of C-kit(+)-expreßing cells derived from neonatal and adult mouse hearts. Circulation. 2010;121:1992-2000.
35. Tallini YN, Greene KS, Craven M, Spealman A, Breitbach M, Smith J, Fisher PJ, Steffey M, Heße M, Doran RM, Woods A, Singh B, Yen A, Fleischmann BK, Kotlikoff MI. c-kit expreßion identifies cardiovascular precursors in the neonatal heart. Proc Natl Acad Sci USA. 2009;106:1808-1813.
36. Ratajczak MZ, Kucia M, Jadczyk T, Greco NJ, Wojakowski W, Tendera M, Ratajczak J. Pivotal role of paracrine effects in stem cell therapies in regenerative medicine: can we translate stem cell-secreted paracrine factors and microvesicles into better therapeutic strategies? Leukemia. 2012;26:1166-1173.
37. Zhou B, Honor LB, He H, Ma Q, Oh JH, Butterfield C, Lin RZ, Melero-Martin JM, Dolmatova E, Duffy HS, Gise Av, Zhou P, Hu YW, Wang G, Zhang B, Wang L, Hall JL, Moses MA, McGowan FX, Pu WT. Adult mouse epicardium modulates myocardial injury by secreting paracrine factors. J Clin Invest. 2011;121:1894-1904.
38. Smart N, Bollini S, Dubé KN, Vieira JM, Zhou B, Davidson S, Yellon D, Riegler J, Price AN, Lythgoe MF, Pu WT, Riley PR. De novo cardiomyocytes from within the activated adult heart after injury. Nature. 2011;474:640-644.
39. Limana F, Bertolami C, Mangoni A, Di Carlo A, Avitabile D, Mocini D, Iannelli P, De Mori R, Marchetti C, Pozzoli O, Gentili C, Zacheo A, Germani A, Capogroßi MC. Myocardial infarction induces embryonic reprogramming of epicardial c-kit(+) cells: role of the pericardial fluid. J Mol Cell Cardiol. 2010;48:609-618.
40. Bax NA, van Oorschot AA, Maas S, Braun J, van Tuyn J, de Vries AA, Groot AC, Goumans MJ. In vitro epithelial-to-mesenchymal transformation in human adult epicardial cells is regulated by TGFß-signaling and WT1. Basic Res Cardiol. 2011;106:829-847.
41. Winter EM, Gittenberger-de Groot AC. Epicardium-derived cells in cardiogenesis and cardiac regeneration. Cell Mol Life Sci. 2007;64: 692-703.
42. Banai S, Jaklitsch MT, Shou M, Lazarous DF, Scheinowitz M, Biro S, Epstein SE, Unger EF. Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs. Circulation. 1994;89:2183-2189.
43. Lazarous DF, Scheinowitz M, Shou M, Hodge E, Rajanayagam S, Hunsberger S, Robison WG Jr, Stiber JA, Correa R, Epstein SE. Effects of chronic systemic administration of basic fibroblast growth factor on collateral development in the canine heart. Circulation. 1995;91:145-153.
44. Zhou B, Honor LB, Ma Q, Oh JH, Lin RZ, Melero-Martin JM, von Gise A, Zhou P, Hu T, He L, Wu KH, Zhang H, Zhang Y, Pu WT. Thymosin beta 4 treatment after myocardial infarction does not reprogram epicardial cells into cardiomyocytes. J Mol Cell Cardiol. 2012;52:43-47.
45. von Gise A, Pu WT. Endocardial and epicardial epithelial to mesenchymal transitions in heart development and disease. Circ Res. 2012;110:1628-1645.